PhD We knew nothing about the set-point viral loads. What was unknown about HIV-1 infection before this paper was published in 2007? 1.Virus density.

Slides:



Advertisements
Similar presentations
Andrea M. Landis, PhD, RN UW LEAH
Advertisements

1 Severe morbidity among HIV- infected patients : a comparison between a Brazilian and a French clinic based observational cohort FIOCRUZ: Prof B Grinsztejn.
The Connection Between STDs and HIV
Kuala Lumpur, July 2nd 2013 The ANRS International VISCONTI Post Treatment Controller Cohort.
Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.
What is Epidemiology? (1)
Disease emergence in immunocompromised populations Jamie Lloyd-Smith Penn State University.
Issues in Genital Herpes
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
National Institute for Public Health and the Environment Comparison of network models for STI transmission and intervention: how useful are they for public.
Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Reading the Dental Literature
A Brief Introduction to Epidemiology - VII (Epidemiologic Research Designs: Demographic, Mortality & Morbidity Studies) Betty C. Jung, RN, MPH, CHES.
1 Research Methods in Clinical Psychology Carolyn R. Fallahi, Ph. D.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
POSTULATES FOR EVOLUTION VIA NATURAL SELECTION 1. Phenotypic variation is present among individuals in the population 2. At least some of this phenotypic.
HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,
HIV in CUBA Kelvin Chan & Sasha Jilkine. Developing a Model S = Susceptible I = Infected Z = AIDS Patients N = S+I = Active Population.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Introduction to Epidemiology Manish Chaudhary. Basic Concept in Epidemiology Epidemiology is the study of the occurrence, distribution and determinants.
Descriptive Epidemiology
Infectious Disease Epidemiology Sharyn Orton, Ph.D. American Red Cross, Rockville, MD Suggested reading: Modern Infectious Disease Epidemiology (1994)
Introduction to Epidemiology
Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.
Modeling the population dynamics of HIV/AIDS Brandy L. Rapatski James A. Yorke Frederick Suppe.
Discussion Gitanjali Batmanabane MD PhD. Do you look like this?
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Clinical Care of HIV, AIDS and Opportunistic Infections
Random Sampling, Point Estimation and Maximum Likelihood.
Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.
LESSON 9.5: TYPES OF STUDIES Module 9: Epidemiology Obj. 9.5: Compare & contrast different types of epidemiological studies.
A Mathematical Model of Cytomegalovirus (CMV) Infection in Transplant Patients Grace M. Kepler Center for Research in Scientific Computation North Carolina.
Modelling infectious diseases Jean-François Boivin 25 October
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
1 An Interim Monitoring Approach for a Small Sample Size Incidence Density Problem By: Shane Rosanbalm Co-author: Dennis Wallace.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
1 Copyright © 2011 by Saunders, an imprint of Elsevier Inc. Chapter 8 Clarifying Quantitative Research Designs.
Cohort Study. Objectives To discuss cohort study designs To discuss data from some cohort studies.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
Effect of antiviral use on the emergence of resistance to nucleoside analogs in Herpes Simplex Virus, Type 1 Marc Lipsitch, Bruce Levin, Rustom Antia,
Describing the risk of an event and identifying risk factors Caroline Sabin Professor of Medical Statistics and Epidemiology, Research Department of Infection.
Roghayeh parsaee  These approaches assume that the study sample arises from a homogeneous population  focus is on relationships among variables 
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
SIR Epidemic and Vaccination
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
Behavioral Research and STIs Objectives l Discuss how behavior influences the basic reproductive rate of an epidemic l Describe some of the behavioral.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
The Contribution of Early HIV Infection to HIV Spread in Lilongwe, Malawi: Implications for Transmission Prevention Strategies Kimberly Powers, 1 Azra.
Risk of Sexual Transmission under HAART Background information on Swiss statement Pietro Vernazza President EKAF- Swiss Federal Commission on AIDS.
1 Research Methods in Child Psychopathology Carolyn R. Fallahi, Ph. D.
© Imperial College LondonPage 1 Understanding the current spread of HIV Geoff Garnett.
Herpes Simplex Virus Type 2 infection among U.S. military service members: Public Health Implications and Opportunities for HIV Prevention Christian T.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Question 1 A new test to diagnose urinary tract infections (UTIs) is being evaluated. The sensitivity of the test is 70% and the specificity is 90%. In.
Imperial College London
Hepatitis C.
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
COMBINATION PREVENTION
Sarah Hawkes, Paz Bailey G, Sternberg M, Lewis DA and Puren A
Modelling infectious diseases
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Presentation transcript:

PhD

We knew nothing about the set-point viral loads. What was unknown about HIV-1 infection before this paper was published in 2007? 1.Virus density predict the probability of transmission between discordant couples. 2.They have the greatest epidemiological impact, in terms of leading to the greatest number of infections over the lifetime of the host. 3.Viral load is heterogeneous both within patients over time and between patients. 4.During the long asymptomatic period of infection, viral loads fluctuate around a steady set-point value, which varies up to 1,000-fold between patient. 5.Patients with higher viral loads will be more infectious. 6.Individuals with a poorer prognosis will have fewer lifetime opportunities for transmission. BUT….

Hypothesis? To determine the epidemiological impact of cross-sectional variation in viral load. What is the aim of this study? They estimated the product of infectiousness and duration of infection, which we term the transmission potential. TP= infectiousness x duration of infection This is the mean number of persons one index case can potentially infect over their whole asymptomatic period, estimated as a function of set-point viral load. How do they do that? Set-point viral loads is the geometric mean viral load in the interval between the end of primary infection (defined as 6 months after first seropositive sample) and the first AIDS-defining event (CDC type C) or censoring, whichever occurs first.

Methods? Describe the Amsterdam Seroconverters Cohort. Asymptomatic Duration as a Function of Viral Load. Infectiousness as a Function of Viral Load. Transmission Potential. Viral load was measured by quantitative PCR from frozen sera

Results? Set-Point Viral Load and the Duration of Asymptomatic Infection. Distribution of set-point viral loads Set-point viral load and duration of asymptomatic infection. The mean duration, in years, of the asymptomatic stage of infection is estimated as a function of viral load

Infectiousness and Viral Load. Set-point viral load and infectiousness. The transmission rate per year within a stable discordant partnership is estimated as a function of viral load.

Consequences of Variation in Set-Point Viral Load for Public Health. The relation between the duration of asymptomatic infection and set-point viral load is similar in some different settings, but this may not be universal. Although indirect population benefits of mass therapy are possible and desirable, treatment protocols in areas of limited resource should use other inclusion criteria, such as clinical need, likelihood of treatment adherence, or sexual behavior. If the intervention reduces patients’ viral load in such a way as to increase their transmission potential on average, then incidence will increase, not decrease

Which hypothesis was proposed on the evolution of HIV-1 virulence? The viral load that maximizes the transmission potential is 4.52 log10 copies per milliliter = 4.36 log10 Dutch cohort = 4.74 log10 Zambian cohorts This means that viral loads during the asymptomatic period are clustered around values that maximize the transmission potential of the virus. If natural selection acts on HIV-1, how will it work? “If a trait is heritable, the conclusion that natural selection can act on it follows automatically. Conversely, if this is not the case, it is impossible for natural selection to act on a trait, no matter what its relationship to fitness might be.”

Conclusions? The transmission potential as a function of set-point viral load and find that it is maximized for intermediate viral loads, which we observe are also the most common among untreated patients. This situation could have arisen because of adaptive evolution of HIV-1 to maximize transmission between humans, although the agreement between observed viral loads and the maximum of the transmission potential could also, of course, be an interesting coincidence. The phenomenon of adaptive virulence, if verified, would have practical consequences in terms of the potential for public health interventions to impact on virulence.